ABSTRACT
We report acute encephalopathy associated with influenza A infection in 3 adults. We detected high cerebrospinal fluid (CSF) and plasma concentrations of CXCL8/IL-8 and CCL2/MCP-1 (CSF/plasma ratios > or =3), and interleukin-6, CXCL10/IP-10, but no evidence of viral neuroinvasion. Patients recovered without sequelae. Hyperactivated cytokine response may play a role in pathogenesis.
Subject(s)
Encephalitis, Viral/virology , Influenza A virus , Influenza, Human/virology , Aged , Aged, 80 and over , Cytokines/physiology , Encephalitis, Viral/complications , Female , Humans , Influenza, Human/complications , MaleABSTRACT
The proportion of elderly people in China is projected to increase rapidly but there is limited information on status epilepticus (SE) in this population. We evaluated retrospectively the etiology, response to treatment, outcome and predictors of mortality in a group of elderly patients with generalized tonic-clonic SE in Hong Kong, China. Factors for increased mortality were analyzed using a logistic regression model. Of the 80 acute admissions for SE from two large urban hospitals over a seven-year period, 1996-2002, the two leading causes were attributed to cerebral infarct (n=28, 35%) and cerebral haemorrhage (n=14, 17.5%). The mean age was 74.2 years (range 60-93 years). At six months from the onset of seizures, 26 patients (32.5%) had made a good recovery but another 28 (35%) had died. Results showed that mortality was associated with increasing age (OR 1.08, 95% CI 1.01-1.16) and SE due to an acute symptomatic disturbance (OR 4.90, 95% CI 1.17-13.67). SE is associated with significant morbidity and mortality in this age group.
Subject(s)
Aged/statistics & numerical data , Epilepsy, Generalized/epidemiology , Epilepsy, Tonic-Clonic/epidemiology , Status Epilepticus/epidemiology , Age of Onset , Aged, 80 and over , China/epidemiology , Epilepsy, Generalized/mortality , Epilepsy, Generalized/therapy , Epilepsy, Tonic-Clonic/mortality , Epilepsy, Tonic-Clonic/therapy , Female , Hong Kong/epidemiology , Humans , Male , Middle Aged , Status Epilepticus/mortality , Status Epilepticus/therapy , Terminology as Topic , Treatment OutcomeABSTRACT
BACKGROUND: In general vagus nerve stimulation (VNS) can serve as an adjunctive treatment for patients with refractory partial-onset seizures. And we evaluated the long-term efficacy and safety of VNS in a group of Chinese patients with refractory epilepsy. METHODS: Of 127 patients with refractory epilepsy, 13 patients who were not eligible for surgical intervention were implanted with the Cyberonics VNS system. Seizure frequency, physical examination and side effects profile were recorded at follow-up visits for a minimum of 18 months. RESULTS: Mean duration of treatment was 47.4 months, and the longest follow-up period was 71 months. Mean baseline seizure frequency was 26.6 seizures per month. The mean percentage reductions in convulsions were 33.2%, 47.1% and 40.0% at 6, 12 and 18 months, respectively. One patient became seizure free, and six (46%) had 50% or more reduction in seizure frequency. Response was poor (< 20% reduction) in five patients (39%). Side effects were uncommon. CONCLUSIONS: The effectiveness of VNS was sustained and was well tolerated but benefited only a sub-group of patients with intractable convulsions.
